Estimated costs of Treatment-Related Adverse Events (TRAES) for Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN) in the checkmate 141 trial
Key Publications on immunotherapy and electrochemotherapy
Chairpersons :
Ashok Mehta
Reviewer :
Priyanka Srivastav